Pharma C Investments - Notice of General Meeting
Announcement provided by
Mortgage Chat PLC · MCAI08/09/2023 14:55
8 September 2023
Notice of General Meeting
Pharma C Investments Plc ("Pharma C" or the "Company") announces that, further to the announcement of 23 August 2023, a general meeting of the Company ("GM") will be held at 10am on Wed 27 September 2023 at the offices of Hill Dickinson LLP. Notice will shortly be posted to shareholders and will be available on the Company's website.
The GM was requisitioned by Paul Ryan, a shareholder holding more than 5% of the issued share capital of the Company to consider the following resolutions:
1. THAT Gavin Hilary Sathianathan be removed as a director of the Company with immediate effect
2. THAT Paul Ryan be appointed as a director of the Company
3. THAT Noel Lyons be appointed as a director of the Company
The Board recommends that shareholders vote against all the resolutions and has set out the reasons for this in the shareholder circular.
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of
The Directors of Pharma C accept responsibility for this announcement.
END
For additional information please contact:
Pharma C Investments
Gavin Sathianathan, Investment Strategy Director
gavin@pharmacinvestments.com
Novum Securities (AQSE Corporate Adviser)
Tel: +44 207 399 9400
David Coffman
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.